Quarfloxin

CX-3543 · Cylene Pharmaceuticals

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Quarfloxin, covering 2009-08-10 to 2011-06-15. Get the full timeline:

Most recent: Clinical Trial Update: Quarfloxin in Patients With Low to Intermediate Grade Neuroendocrine Carcinoma [Phase 2]